1. Home
  2. LVRO vs HUMA Comparison

LVRO vs HUMA Comparison

Compare LVRO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lavoro Limited

LVRO

Lavoro Limited

HOLD

Current Price

$0.69

Market Cap

112.6M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.16

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVRO
HUMA
Founded
2017
2004
Country
Brazil
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.6M
236.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LVRO
HUMA
Price
$0.69
$1.16
Analyst Decision
Sell
Strong Buy
Analyst Count
3
8
Target Price
$1.88
$10.13
AVG Volume (30 Days)
14.6K
4.2M
Earning Date
02-02-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,667,345,189.00
$1,571,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$11.45
$731.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$1.06
52 Week High
$5.60
$6.77

Technical Indicators

Market Signals
Indicator
LVRO
HUMA
Relative Strength Index (RSI) 26.85 41.71
Support Level $0.60 $1.06
Resistance Level $0.69 $1.32
Average True Range (ATR) 0.11 0.08
MACD -0.00 -0.00
Stochastic Oscillator 6.58 37.48

Price Performance

Historical Comparison
LVRO
HUMA

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: